Pasient with TLS who have rising phosphate, LDH and bilirubin, normal potasium

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 20 May 2026Updated: 20 May 2026 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

Hemodialysis in tumor lysis syndrome (TLS) should be considered when there are life-threatening or refractory metabolic disturbances, or when renal function deteriorates despite medical management. In the patient described, despite effective rasburicase therapy leading to low uric acid levels and maintenance of a stable estimated glomerular filtration rate (eGFR) of 20 mL/min, the patient has rising phosphate, lactate dehydrogenase (LDH), and bilirubin levels, normal potassium, and significant diuresis (~2 liters). These findings indicate ongoing cell lysis and metabolic disturbance but with preserved urine output and stable renal function.,,



UK clinical guidance emphasizes aggressive hydration and monitoring in TLS to maintain urine output and prevent uric acid and calcium-phosphate crystallization. Rasburicase rapidly decreases plasma uric acid by enzymatic conversion to allantoin, improving renal function and aiding phosphate excretion to prevent further renal damage from calcium-phosphate precipitation. However, management of hyperphosphatemia can be challenging, particularly with compromised renal function, and phosphate binders or dialysis may be required if levels become severe and uncontrollable medically.



Despite a stable eGFR and urine output, the rising phosphate and bilirubin suggest progressive metabolic imbalance and possible worsening kidney insult or ongoing cell turnover. According to NICE CKS guidance on acute kidney injury (AKI) and TLS, renal replacement therapy (RRT), including hemodialysis, should be considered when metabolic abnormalities such as hyperkalemia, hyperphosphatemia, or uraemia do not respond to medical management, or if there is fluid overload or pulmonary oedema.,



In this scenario, the normal potassium is reassuring, but phosphate is rising, which can cause nephrocalcinosis, and elevated LDH and bilirubin may reflect ongoing hemolysis or tumor lysis burden. The stable GFR of 20 mL/min indicates stage 4 chronic kidney disease, so the renal reserve is limited. Two liters of diuresis is relatively robust and suggests some preservation of renal clearance function.,



Therefore, based on currently available evidence and UK guidelines, immediate initiation of hemodialysis is not mandatory but should be strongly considered if the hyperphosphatemia worsens, metabolic derangements become refractory to medical management, or if renal function deteriorates further. Close clinical and laboratory monitoring is mandatory, with particular attention to potassium, phosphate, calcium, uric acid, and signs of volume overload.,,,



Consultation with nephrology and oncology specialists is advised for dynamic assessment and early initiation of RRT if clinical or biochemical parameters worsen despite optimal medical treatment., Protection against volume overload, electrolyte disturbances, and uraemia guides initiation of dialysis, rather than solely the eGFR or urine output.,

Related Knowledge Topics

Educational content only. Always verify information and use clinical judgement.

Pasient With Tls Who Have Rising Phosphate, Ldh and Bilirubin, Normal